Close Menu

John Innes Centre

Differences in gene expression affect how plants develop different leaf shapes, Smithsonian Magazine reports.

Participants aim to use predictive modeling to better understand epigenetic mechanisms, while encouraging the development of new technologies and therapies.

The consortium sequenced the bread wheat variety Chinese Spring, which has been used to develop genetic resources used by wheat researchers.

The method helps break up the genome by chromosome and reduces the complexity of identifying target genes, which is particularly useful for certain plant genomes.

NEW YORK (GenomeWeb News) – The UK's Biotechnology and Biological Sciences Research Council will invest £19 million ($29.8 million) in the Genome Analysis Center at the Norwich Research Park in the UK as part of a broader, five-year £250 million ($392 million) investment in the biosciences.

The John Innes Centre will provide expertise to the Malaysian Genomics Resource Centre for research into agricultural and bioactive compounds.

A UK consortium will use the funds to study wheat variations that could be used to develop more sustainable, higher-yielding crops.

TraitTag was developed by researchers at the John Innes Centre to identify SNPs associated with positive traits in massive sets of plant genome data generated with Illumina's Genome Analyzer.

Short Reads: Feb 17, 2009

Premium

Life Technologies, Max Planck Institute for Evolutionary Anthropology, 454 Life Sciences, Applied Biosystems, Baylor College of Medicine, University of Bristol, University of Liverpool, John Innes Centre, Helicos BioSciences, Febit, and more…

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.